|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/437 | |||
| A61P 25/28 |
| (11) | Patento numeris | 3532477 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17794524.3 |
| Europos patento paraiškos padavimo data | 2017-10-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/057566 |
| Data | 2017-10-20 |
| (87) | Numeris | WO 2018/080917 |
| Data | 2018-05-03 |
| (30) | Numeris | Data | Šalis |
| 201662412868 P | 2016-10-26 | US |
| (72) |
AMERIKS, Michael K., US
GYURIS, Mįri, HU
LAFORTEZA, Brian Ngo, US
LEBOLD, Terry Patrick, US
MEYER, Stephen Todd, US
RAVULA, Suchitra, US
SAVALL, Brad M., US
SHIREMAN, Brock T., US
WADE, Warren Stanfield, US
GERENCSÉR, Jįnos, HU
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| FUSED BICYLIC PYRIDINE COMPOUNDS AND THEIR USE AS AMPA RECEPTOR MODULATORS |